SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001801777-23-000025
Filing Date
2023-03-27
Accepted
2023-03-27 16:03:19
Documents
14
Period of Report
2023-03-21
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K amti-20230321.htm   iXBRL 8-K 40433
2 EX-99.1 amti-20220327xexx991.htm EX-99.1 9884
6 image_0.jpg GRAPHIC 49503
  Complete submission text file 0001801777-23-000025.txt   254053

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amti-20230321.xsd EX-101.SCH 1905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amti-20230321_lab.xml EX-101.LAB 23832
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amti-20230321_pre.xml EX-101.PRE 12510
8 EXTRACTED XBRL INSTANCE DOCUMENT amti-20230321_htm.xml XML 4294
Mailing Address 450 EAST JAMIE COURT SOUTH SAN FRANCISCO CA 94080
Business Address 450 EAST JAMIE COURT SOUTH SAN FRANCISCO CA 94080 650-392-0420
Applied Molecular Transport Inc. (Filer) CIK: 0001801777 (see all company filings)

IRS No.: 814481426 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39306 | Film No.: 23764528
SIC: 2834 Pharmaceutical Preparations